Ticker Details
OPKO Health, Inc. OPKO Health Inc is a diversified healthcare company. Its business includes diagnostics and provision of pharmaceutical products.
IPO Date:	November 2, 1995
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$921.24M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.11 | 2.71%
Avg Daily Range (30 D):	$0.02 | 1.46%
Avg Daily Range (90 D):	$0.02 | 1.66%

Institutional Daily Volume
Avg Daily Volume:	3.3M
Avg Daily Volume (30 D):	2.52M
Avg Daily Volume (90 D):	2.54M

Trade Size
Avg Trade Size (Sh.):	298
Avg Trade Size (Sh.) (30 D):	386
Avg Trade Size (Sh.) (90 D):	350

Institutional Trades
Total Institutional Trades:	4,504
Avg Institutional Trade:	$1.81M
Avg Institutional Trade (30 D):	$.9M
Avg Institutional Trade (90 D):	$1.26M
Avg Institutional Trade Volume:	.39M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2M
Avg Closing Trade (30 D):	$.83M
Avg Closing Trade (90 D):	$1.27M
Avg Closing Volume:	451.78K

News

Feb 12, 2026 @ 1:00 PM OPKO Health to Report Fourth Quarter 2025 Financia... Source: Na

Feb 4, 2026 @ 1:00 PM OPKO Health and Entera Bio Expand Partnership to A... Source: Opko Health, Inc. And Entera Bio Ltd.

Nov 18, 2025 @ 1:00 PM Entera Bio to Participate in the 8th Annual Everco... Source: Miranda Toledano

Oct 8, 2025 @ 12:02 PM NextPlat Issues CEO Shareholder Update Letter Source: David Phipps

Aug 8, 2025 @ 9:17 PM Entera Bio Beats Q2 EPS Estimates Source: Jesterai

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS		$.03	$-.19
Diluted EPS		$.03	$-.19
Revenue		$151.67M	$156.81M
Gross Profit		$49.89M	$49.4M
Net Income / Loss		$21.63M	$-148.44M
Operating Income / Loss		$48.06M	$-59.98M
Cost of Revenue		$101.78M	$107.41M
Net Cash Flow		$143.8M	$-165.74M
PE Ratio